Furthermore, our study supports the findings of Niederkorn et al., which suggests that CXCL13 is an activity marker for systemic but not cutaneous lupus erythematosus, authenticating its role in predicting systemic disease (46, 47). This evidence concerns the gene CXCL13 and cutaneous lupus erythematosus.